Report Thumbnail
Product Code QY0914412486URG
Published Date 2024/4/19
English184 PagesGlobal

Global Clinical Trial Translation Service Market Insights, Forecast to 2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code QY0914412486URG◆The Apr 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/4/19
English 184 PagesGlobal

Global Clinical Trial Translation Service Market Insights, Forecast to 2030Pharmaceutical_LifeSciense Market



Abstract


Summary

Clinical trial translation service refers to the specialized translation of clinical trial documents, including protocols, informed consent forms, regulatory submissions, patient information leaflets, and study reports, from one language to another. These translations are essential for ensuring accurate and culturally appropriate communication between researchers, sponsors, regulatory authorities, healthcare professionals, and study participants across different linguistic regions. Clinical trial translation services require expertise in medical terminology, regulatory requirements, and cultural nuances to accurately convey scientific information while maintaining consistency, clarity, and compliance with regulatory standards. Translators working in this field often have backgrounds in medicine, pharmacy, or life sciences, along with proficiency in multiple languages and translation technologies. Additionally, clinical trial translation services may include back-translation, linguistic validation, and certification processes to ensure the accuracy and reliability of translated documents for regulatory submission and ethical review. Overall, clinical trial translation services play a critical role in facilitating multinational clinical research, ensuring patient safety, and maintaining regulatory compliance in the global healthcare landscape.
The global Clinical Trial Translation Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The clinical trial translation service market is experiencing significant growth driven by the globalization of clinical research, increasing regulatory requirements, and the expanding diversity of patient populations participating in clinical trials worldwide. Currently, the market is characterized by a rising demand for high-quality translation services for clinical trial documents such as protocols, informed consent forms, regulatory submissions, and patient information leaflets. As clinical trials become increasingly multinational and collaborative, there is a growing need for accurate and culturally appropriate translations to ensure effective communication among researchers, sponsors, regulatory authorities, and study participants across different linguistic regions. Moreover, with the emergence of precision medicine and personalized therapies, there is a heightened focus on the translation of complex scientific and medical content to facilitate patient understanding and engagement in clinical trials. Looking ahead, future development trends in the clinical trial translation service market are expected to focus on innovation, automation, and integration with digital technologies. This includes the adoption of machine translation, natural language processing (NLP), and artificial intelligence (AI) algorithms to improve translation speed, accuracy, and cost-effectiveness. Additionally, there is a growing emphasis on the development of specialized translation platforms and tools tailored to the unique requirements of clinical research, such as integrated terminology databases, regulatory compliance checks, and secure data management systems. Furthermore, as regulatory standards continue to evolve and become more stringent, there will be an increasing demand for translation services that ensure compliance with international regulations and standards such as Good Clinical Practice (GCP) and the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). Overall, the clinical trial translation service market is poised for continued growth and innovation as stakeholders seek to overcome language barriers, enhance patient recruitment and retention, and improve the efficiency and effectiveness of multinational clinical trials.
Report Includes
This report presents an overview of global market for Clinical Trial Translation Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Clinical Trial Translation Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Clinical Trial Translation Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Clinical Trial Translation Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Clinical Trial Translation Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Clinical Trial Translation Service revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Language Scientific, Lionbridge, DTS Language Services, Mars Translation, ILS, TransPerfect, Intertranslations, Translate By Humans, GTS, ASTA-USA, etc.
Market Segmentation
By Company
Language Scientific
Lionbridge
DTS Language Services
Mars Translation
ILS
TransPerfect
Intertranslations
Translate By Humans
GTS
ASTA-USA
Sawatech
TranslationPartner
Ulatus
TransPalm
EC Innovations
Conversis
Novalins
ITC
Tomedes
The Translation People
BURG
Absolute Translations
Questel
AsiaLocalize
London Translations
ICON
Thao & Co.
Welocalize Life Sciences
CSOFT
Segment by Type
Written Translation
Oral Translation
Segment by Application
Pharmaceutical Company
Biotechnology Company
Medical Device Company
Clinical Research Organization
Medical Institution
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of South America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Clinical Trial Translation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Translation Service companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial Translation Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

  • 1 Report Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global Clinical Trial Translation Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
      • 1.2.2 Written Translation
      • 1.2.3 Oral Translation
    • 1.3 Market by Application
      • 1.3.1 Global Clinical Trial Translation Service Market Share by Application: 2019 VS 2023 VS 2030
      • 1.3.2 Pharmaceutical Company
      • 1.3.3 Biotechnology Company
      • 1.3.4 Medical Device Company
      • 1.3.5 Clinical Research Organization
      • 1.3.6 Medical Institution
      • 1.3.7 Others
    • 1.4 Assumptions and Limitations
    • 1.5 Study Objectives
    • 1.6 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global Clinical Trial Translation Service Market Perspective (2019-2030)
    • 2.2 Global Clinical Trial Translation Service Growth Trends by Region
      • 2.2.1 Global Clinical Trial Translation Service Market Size by Region: 2019 VS 2023 VS 2030
      • 2.2.2 Clinical Trial Translation Service Historic Market Size by Region (2019-2024)
      • 2.2.3 Clinical Trial Translation Service Forecasted Market Size by Region (2025-2030)
    • 2.3 Clinical Trial Translation Service Market Dynamics
      • 2.3.1 Clinical Trial Translation Service Industry Trends
      • 2.3.2 Clinical Trial Translation Service Market Drivers
      • 2.3.3 Clinical Trial Translation Service Market Challenges
      • 2.3.4 Clinical Trial Translation Service Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Revenue Clinical Trial Translation Service by Players
      • 3.1.1 Global Clinical Trial Translation Service Revenue by Players (2019-2024)
      • 3.1.2 Global Clinical Trial Translation Service Revenue Market Share by Players (2019-2024)
    • 3.2 Global Clinical Trial Translation Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.3 Global Key Players of Clinical Trial Translation Service, Ranking by Revenue, 2022 VS 2023 VS 2024
    • 3.4 Global Clinical Trial Translation Service Market Concentration Ratio
      • 3.4.1 Global Clinical Trial Translation Service Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Translation Service Revenue in 2023
    • 3.5 Global Key Players of Clinical Trial Translation Service Head office and Area Served
    • 3.6 Global Key Players of Clinical Trial Translation Service, Product and Application
    • 3.7 Global Key Players of Clinical Trial Translation Service, Date of Enter into This Industry
    • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 Clinical Trial Translation Service Breakdown Data by Type

    • 4.1 Global Clinical Trial Translation Service Historic Market Size by Type (2019-2024)
    • 4.2 Global Clinical Trial Translation Service Forecasted Market Size by Type (2025-2030)
  • 5 Clinical Trial Translation Service Breakdown Data by Application

    • 5.1 Global Clinical Trial Translation Service Historic Market Size by Application (2019-2024)
    • 5.2 Global Clinical Trial Translation Service Forecasted Market Size by Application (2025-2030)
  • 6 North America

    • 6.1 North America Clinical Trial Translation Service Market Size (2019-2030)
    • 6.2 North America Clinical Trial Translation Service Market Size by Type
      • 6.2.1 North America Clinical Trial Translation Service Market Size by Type (2019-2024)
      • 6.2.2 North America Clinical Trial Translation Service Market Size by Type (2025-2030)
      • 6.2.3 North America Clinical Trial Translation Service Market Share by Type (2019-2030)
    • 6.3 North America Clinical Trial Translation Service Market Size by Application
      • 6.3.1 North America Clinical Trial Translation Service Market Size by Application (2019-2024)
      • 6.3.2 North America Clinical Trial Translation Service Market Size by Application (2025-2030)
      • 6.3.3 North America Clinical Trial Translation Service Market Share by Application (2019-2030)
    • 6.4 North America Clinical Trial Translation Service Market Size by Country
      • 6.4.1 North America Clinical Trial Translation Service Market Size by Country: 2019 VS 2023 VS 2030
      • 6.4.2 North America Clinical Trial Translation Service Market Size by Country (2019-2024)
      • 6.4.3 North America Clinical Trial Translation Service Market Share by Country (2025-2030)
      • 6.4.4 United States
      • 6.4.5 Canada
  • 7 Europe

    • 7.1 Europe Clinical Trial Translation Service Market Size (2019-2030)
    • 7.2 Europe Clinical Trial Translation Service Market Size by Type
      • 7.2.1 Europe Clinical Trial Translation Service Market Size by Type (2019-2024)
      • 7.2.2 Europe Clinical Trial Translation Service Market Size by Type (2025-2030)
      • 7.2.3 Europe Clinical Trial Translation Service Market Share by Type (2019-2030)
    • 7.3 Europe Clinical Trial Translation Service Market Size by Application
      • 7.3.1 Europe Clinical Trial Translation Service Market Size by Application (2019-2024)
      • 7.3.2 Europe Clinical Trial Translation Service Market Size by Application (2025-2030)
      • 7.3.3 Europe Clinical Trial Translation Service Market Share by Application (2019-2030)
    • 7.4 Europe Clinical Trial Translation Service Market Size by Country
      • 7.4.1 Europe Clinical Trial Translation Service Market Size by Country: 2019 VS 2023 VS 2030
      • 7.4.2 Europe Clinical Trial Translation Service Market Size by Country (2019-2024)
      • 7.4.3 Europe Clinical Trial Translation Service Market Size by Country (2025-2030)
      • 7.4.4 Germany
      • 7.4.5 France
      • 7.4.6 U.K.
      • 7.4.7 Italy
      • 7.4.8 Russia
      • 7.4.9 Nordic Countries
  • 8 China

    • 8.1 China Clinical Trial Translation Service Market Size (2019-2030)
    • 8.2 China Clinical Trial Translation Service Market Size by Type
      • 8.2.1 China Clinical Trial Translation Service Market Size by Type (2019-2024)
      • 8.2.2 China Clinical Trial Translation Service Market Size by Type (2025-2030)
      • 8.2.3 China Clinical Trial Translation Service Market Share by Type (2019-2030)
    • 8.3 China Clinical Trial Translation Service Market Size by Application
      • 8.3.1 China Clinical Trial Translation Service Market Size by Application (2019-2024)
      • 8.3.2 China Clinical Trial Translation Service Market Size by Application (2025-2030)
      • 8.3.3 China Clinical Trial Translation Service Market Share by Application (2019-2030)
  • 9 Asia (excluding China)

    • 9.1 Asia Clinical Trial Translation Service Market Size (2019-2030)
    • 9.2 Asia Clinical Trial Translation Service Market Size by Type
      • 9.2.1 Asia Clinical Trial Translation Service Market Size by Type (2019-2024)
      • 9.2.2 Asia Clinical Trial Translation Service Market Size by Type (2025-2030)
      • 9.2.3 Asia Clinical Trial Translation Service Market Share by Type (2019-2030)
    • 9.3 Asia Clinical Trial Translation Service Market Size by Application
      • 9.3.1 Asia Clinical Trial Translation Service Market Size by Application (2019-2024)
      • 9.3.2 Asia Clinical Trial Translation Service Market Size by Application (2025-2030)
      • 9.3.3 Asia Clinical Trial Translation Service Market Share by Application (2019-2030)
    • 9.4 Asia Clinical Trial Translation Service Market Size by Region
      • 9.4.1 Asia Clinical Trial Translation Service Market Size by Region: 2019 VS 2023 VS 2030
      • 9.4.2 Asia Clinical Trial Translation Service Market Size by Region (2019-2024)
      • 9.4.3 Asia Clinical Trial Translation Service Market Size by Region (2025-2030)
      • 9.4.4 Japan
      • 9.4.5 South Korea
      • 9.4.6 China Taiwan
      • 9.4.7 Southeast Asia
      • 9.4.8 India
      • 9.4.9 Australia
  • 10 Middle East, Africa, and Latin America

    • 10.1 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Size (2019-2030)
    • 10.2 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Size by Type
      • 10.2.1 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Size by Type (2019-2024)
      • 10.2.2 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Size by Type (2025-2030)
      • 10.2.3 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Share by Type (2019-2030)
    • 10.3 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Size by Application
      • 10.3.1 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Size by Application (2019-2024)
      • 10.3.2 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Size by Application (2025-2030)
      • 10.3.3 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Share by Application (2019-2030)
    • 10.4 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Size by Country
      • 10.4.1 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Size by Country: 2019 VS 2023 VS 2030
      • 10.4.2 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Size by Country (2019-2024)
      • 10.4.3 Middle East, Africa, and Latin America Clinical Trial Translation Service Market Size by Country (2025-2030)
      • 10.4.4 Brazil
      • 10.4.5 Mexico
      • 10.4.6 Turkey
      • 10.4.7 Saudi Arabia
      • 10.4.8 Israel
      • 10.4.9 GCC Countries
  • 11 Key Players Profiles

    • 11.1 Language Scientific
      • 11.1.1 Language Scientific Company Details
      • 11.1.2 Language Scientific Business Overview
      • 11.1.3 Language Scientific Clinical Trial Translation Service Introduction
      • 11.1.4 Language Scientific Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.1.5 Language Scientific Recent Development
    • 11.2 Lionbridge
      • 11.2.1 Lionbridge Company Details
      • 11.2.2 Lionbridge Business Overview
      • 11.2.3 Lionbridge Clinical Trial Translation Service Introduction
      • 11.2.4 Lionbridge Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.2.5 Lionbridge Recent Development
    • 11.3 DTS Language Services
      • 11.3.1 DTS Language Services Company Details
      • 11.3.2 DTS Language Services Business Overview
      • 11.3.3 DTS Language Services Clinical Trial Translation Service Introduction
      • 11.3.4 DTS Language Services Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.3.5 DTS Language Services Recent Development
    • 11.4 Mars Translation
      • 11.4.1 Mars Translation Company Details
      • 11.4.2 Mars Translation Business Overview
      • 11.4.3 Mars Translation Clinical Trial Translation Service Introduction
      • 11.4.4 Mars Translation Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.4.5 Mars Translation Recent Development
    • 11.5 ILS
      • 11.5.1 ILS Company Details
      • 11.5.2 ILS Business Overview
      • 11.5.3 ILS Clinical Trial Translation Service Introduction
      • 11.5.4 ILS Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.5.5 ILS Recent Development
    • 11.6 TransPerfect
      • 11.6.1 TransPerfect Company Details
      • 11.6.2 TransPerfect Business Overview
      • 11.6.3 TransPerfect Clinical Trial Translation Service Introduction
      • 11.6.4 TransPerfect Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.6.5 TransPerfect Recent Development
    • 11.7 Intertranslations
      • 11.7.1 Intertranslations Company Details
      • 11.7.2 Intertranslations Business Overview
      • 11.7.3 Intertranslations Clinical Trial Translation Service Introduction
      • 11.7.4 Intertranslations Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.7.5 Intertranslations Recent Development
    • 11.8 Translate By Humans
      • 11.8.1 Translate By Humans Company Details
      • 11.8.2 Translate By Humans Business Overview
      • 11.8.3 Translate By Humans Clinical Trial Translation Service Introduction
      • 11.8.4 Translate By Humans Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.8.5 Translate By Humans Recent Development
    • 11.9 GTS
      • 11.9.1 GTS Company Details
      • 11.9.2 GTS Business Overview
      • 11.9.3 GTS Clinical Trial Translation Service Introduction
      • 11.9.4 GTS Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.9.5 GTS Recent Development
    • 11.10 ASTA-USA
      • 11.10.1 ASTA-USA Company Details
      • 11.10.2 ASTA-USA Business Overview
      • 11.10.3 ASTA-USA Clinical Trial Translation Service Introduction
      • 11.10.4 ASTA-USA Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.10.5 ASTA-USA Recent Development
    • 11.11 Sawatech
      • 11.11.1 Sawatech Company Details
      • 11.11.2 Sawatech Business Overview
      • 11.11.3 Sawatech Clinical Trial Translation Service Introduction
      • 11.11.4 Sawatech Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.11.5 Sawatech Recent Development
    • 11.12 TranslationPartner
      • 11.12.1 TranslationPartner Company Details
      • 11.12.2 TranslationPartner Business Overview
      • 11.12.3 TranslationPartner Clinical Trial Translation Service Introduction
      • 11.12.4 TranslationPartner Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.12.5 TranslationPartner Recent Development
    • 11.13 Ulatus
      • 11.13.1 Ulatus Company Details
      • 11.13.2 Ulatus Business Overview
      • 11.13.3 Ulatus Clinical Trial Translation Service Introduction
      • 11.13.4 Ulatus Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.13.5 Ulatus Recent Development
    • 11.14 TransPalm
      • 11.14.1 TransPalm Company Details
      • 11.14.2 TransPalm Business Overview
      • 11.14.3 TransPalm Clinical Trial Translation Service Introduction
      • 11.14.4 TransPalm Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.14.5 TransPalm Recent Development
    • 11.15 EC Innovations
      • 11.15.1 EC Innovations Company Details
      • 11.15.2 EC Innovations Business Overview
      • 11.15.3 EC Innovations Clinical Trial Translation Service Introduction
      • 11.15.4 EC Innovations Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.15.5 EC Innovations Recent Development
    • 11.16 Conversis
      • 11.16.1 Conversis Company Details
      • 11.16.2 Conversis Business Overview
      • 11.16.3 Conversis Clinical Trial Translation Service Introduction
      • 11.16.4 Conversis Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.16.5 Conversis Recent Development
    • 11.17 Novalins
      • 11.17.1 Novalins Company Details
      • 11.17.2 Novalins Business Overview
      • 11.17.3 Novalins Clinical Trial Translation Service Introduction
      • 11.17.4 Novalins Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.17.5 Novalins Recent Development
    • 11.18 ITC
      • 11.18.1 ITC Company Details
      • 11.18.2 ITC Business Overview
      • 11.18.3 ITC Clinical Trial Translation Service Introduction
      • 11.18.4 ITC Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.18.5 ITC Recent Development
    • 11.19 Tomedes
      • 11.19.1 Tomedes Company Details
      • 11.19.2 Tomedes Business Overview
      • 11.19.3 Tomedes Clinical Trial Translation Service Introduction
      • 11.19.4 Tomedes Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.19.5 Tomedes Recent Development
    • 11.20 The Translation People
      • 11.20.1 The Translation People Company Details
      • 11.20.2 The Translation People Business Overview
      • 11.20.3 The Translation People Clinical Trial Translation Service Introduction
      • 11.20.4 The Translation People Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.20.5 The Translation People Recent Development
    • 11.21 BURG
      • 11.21.1 BURG Company Details
      • 11.21.2 BURG Business Overview
      • 11.21.3 BURG Clinical Trial Translation Service Introduction
      • 11.21.4 BURG Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.21.5 BURG Recent Development
    • 11.22 Absolute Translations
      • 11.22.1 Absolute Translations Company Details
      • 11.22.2 Absolute Translations Business Overview
      • 11.22.3 Absolute Translations Clinical Trial Translation Service Introduction
      • 11.22.4 Absolute Translations Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.22.5 Absolute Translations Recent Development
    • 11.23 Questel
      • 11.23.1 Questel Company Details
      • 11.23.2 Questel Business Overview
      • 11.23.3 Questel Clinical Trial Translation Service Introduction
      • 11.23.4 Questel Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.23.5 Questel Recent Development
    • 11.24 AsiaLocalize
      • 11.24.1 AsiaLocalize Company Details
      • 11.24.2 AsiaLocalize Business Overview
      • 11.24.3 AsiaLocalize Clinical Trial Translation Service Introduction
      • 11.24.4 AsiaLocalize Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.24.5 AsiaLocalize Recent Development
    • 11.25 London Translations
      • 11.25.1 London Translations Company Details
      • 11.25.2 London Translations Business Overview
      • 11.25.3 London Translations Clinical Trial Translation Service Introduction
      • 11.25.4 London Translations Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.25.5 London Translations Recent Development
    • 11.26 ICON
      • 11.26.1 ICON Company Details
      • 11.26.2 ICON Business Overview
      • 11.26.3 ICON Clinical Trial Translation Service Introduction
      • 11.26.4 ICON Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.26.5 ICON Recent Development
    • 11.27 Thao & Co.
      • 11.27.1 Thao & Co. Company Details
      • 11.27.2 Thao & Co. Business Overview
      • 11.27.3 Thao & Co. Clinical Trial Translation Service Introduction
      • 11.27.4 Thao & Co. Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.27.5 Thao & Co. Recent Development
    • 11.28 Welocalize Life Sciences
      • 11.28.1 Welocalize Life Sciences Company Details
      • 11.28.2 Welocalize Life Sciences Business Overview
      • 11.28.3 Welocalize Life Sciences Clinical Trial Translation Service Introduction
      • 11.28.4 Welocalize Life Sciences Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.28.5 Welocalize Life Sciences Recent Development
    • 11.29 CSOFT
      • 11.29.1 CSOFT Company Details
      • 11.29.2 CSOFT Business Overview
      • 11.29.3 CSOFT Clinical Trial Translation Service Introduction
      • 11.29.4 CSOFT Revenue in Clinical Trial Translation Service Business (2019-2024)
      • 11.29.5 CSOFT Recent Development
  • 12 Analyst's Viewpoints/Conclusions

  • 13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
        • 13.1.1.1 Research Programs/Design
        • 13.1.1.2 Market Size Estimation
        • 13.1.1.3 Market Breakdown and Data Triangulation
      • 13.1.2 Data Source
        • 13.1.2.1 Secondary Sources
        • 13.1.2.2 Primary Sources
    • 13.2 Author Details
    • 13.3 Disclaimer
USD 4,900 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.